chr14-28767768-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP5BA1

This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Gly163= variant in FOXG1 is 0.09% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Gly163= variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Gly163= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP5). LINK:https://erepo.genome.network/evrepo/ui/classification/CA172185/MONDO:0100040/016

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 0 hom. )

Consequence

FOXG1
NM_005249.5 synonymous

Scores

1
1

Clinical Significance

Benign reviewed by expert panel B:8

Conservation

PhyloP100: 1.60

Publications

1 publications found
Variant links:
Genes affected
FOXG1 (HGNC:3811): (forkhead box G1) This locus encodes a member of the fork-head transcription factor family. The encoded protein, which functions as a transcriptional repressor, is highly expressed in neural tissues during brain development. Mutations at this locus have been associated with Rett syndrome and a diverse spectrum of neurodevelopmental disorders defined as part of the FOXG1 syndrome. This gene is disregulated in many types of cancer and is the target of multiple microRNAs that regulate the proliferation of tumor cells. [provided by RefSeq, Jul 2020]
LINC01551 (HGNC:19828): (long intergenic non-protein coding RNA 1551)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP5
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXG1NM_005249.5 linkc.489C>T p.Gly163Gly synonymous_variant Exon 1 of 1 ENST00000313071.7 NP_005240.3 P55316

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXG1ENST00000313071.7 linkc.489C>T p.Gly163Gly synonymous_variant Exon 1 of 1 6 NM_005249.5 ENSP00000339004.3 P55316
FOXG1ENST00000706482.1 linkc.489C>T p.Gly163Gly synonymous_variant Exon 2 of 2 ENSP00000516406.1 P55316
LINC01551ENST00000675861.1 linkn.374+1755C>T intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.000578
AC:
87
AN:
150532
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000596
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000973
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00102
Gnomad OTH
AF:
0.000486
GnomAD2 exomes
AF:
0.000484
AC:
101
AN:
208658
AF XY:
0.000540
show subpopulations
Gnomad AFR exome
AF:
0.000165
Gnomad AMR exome
AF:
0.000375
Gnomad ASJ exome
AF:
0.000108
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000159
Gnomad NFE exome
AF:
0.000825
Gnomad OTH exome
AF:
0.00111
GnomAD4 exome
AF:
0.000741
AC:
1049
AN:
1414872
Hom.:
0
Cov.:
37
AF XY:
0.000772
AC XY:
542
AN XY:
701940
show subpopulations
African (AFR)
AF:
0.000153
AC:
5
AN:
32748
American (AMR)
AF:
0.000444
AC:
19
AN:
42750
Ashkenazi Jewish (ASJ)
AF:
0.0000389
AC:
1
AN:
25690
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38802
South Asian (SAS)
AF:
0.0000598
AC:
5
AN:
83600
European-Finnish (FIN)
AF:
0.0000981
AC:
4
AN:
40782
Middle Eastern (MID)
AF:
0.000412
AC:
2
AN:
4850
European-Non Finnish (NFE)
AF:
0.000903
AC:
981
AN:
1086774
Other (OTH)
AF:
0.000544
AC:
32
AN:
58876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
56
113
169
226
282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000578
AC:
87
AN:
150532
Hom.:
0
Cov.:
32
AF XY:
0.000626
AC XY:
46
AN XY:
73444
show subpopulations
African (AFR)
AF:
0.000171
AC:
7
AN:
40928
American (AMR)
AF:
0.000596
AC:
9
AN:
15110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5130
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4762
European-Finnish (FIN)
AF:
0.0000973
AC:
1
AN:
10282
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00102
AC:
69
AN:
67578
Other (OTH)
AF:
0.000486
AC:
1
AN:
2058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000763
Hom.:
0
Bravo
AF:
0.000525

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 22, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

FOXG1: BP4, BP7 -

Dec 31, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 10, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

FOXG1 disorder Benign:1
Mar 26, 2021
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The allele frequency of the p.Gly163= variant in FOXG1 is 0.09% in European (Non-Finnish) sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). The p.Gly163= variant is found in a patient with an alternate molecular basis of disease (internal database) (BP5). In summary, the p.Gly163= variant in FOXG1 is classified as benign based on the ACMG/AMP criteria (BA1, BP5). -

FOXG1-related disorder Benign:1
Sep 30, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Rett syndrome, congenital variant Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
14
DANN
Uncertain
0.98
PhyloP100
1.6
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375378714; hg19: chr14-29236974; API